Vistin Pharma is strongly committed to maintaining an open dialogue with our shareholders, potential investors, analysts, investment banks and the financial markets.

Our goal is for the share price to reflect the underlying value of the company by providing all price-relevant information to the market.
Last updated 29.03 2022 11:00
Nok 16,80
Since open-0,30 (-1.70%)
Since previous close +0,44 (+2.60%)

8 reasons for investing in Vistin Pharma ASA.

Leading Producer
Amongst Top 5 producers of metformin HCl globally
High Quality Reputation
Leading reputation as producer of high quality APIs with strong track record of customer delivery
Attractive Market Dynamics
Established position in growing metformin market
Diverse Client Portfolio
Established client base comprising mix of Big Pharma and leading generics players
Sustained Revenue Growth
Strong growth profile with double digit revenue growth in the last 5 years
Advanced Manufacturing Facilities
State of the art and dedicated manufacturing facility with potential for further expansion
Strong Leadership
Experienced management team with a strong track record
A Front-runner
Leading the ESG culture in the industry

Quarterly Results

Annual Reports

Other downloads

Investor calendar

Main shareholders

NAME

PER OCTOBER 2022

SHAREHOLDING

% SHARE

1
INTERTRADE SHIPPING AS*
12 575 000
28,4 %
2
PACTUM VEKST AS*
3
HOLMEN SPESIALFOND
4
MP PENSJON PK
3 519 733
7,9 %
5
FERNCLIFF LISTED DAI AS*
6
AUGUST RINGVOLD AGENTUR AS
3 250 000
7,3 %
7
STORKLEIVEN AS
8
LUCELLUM  AS
1 719 848
3,9 %
9
DNB  BANK ASA
10
MIKLA  INVEST AS
784 280
1,8 %
11
IVAR  LØGES STIFTELSE
12
TOM  RAGNAR PRESTEGÅRD STAAVI
750 315
1,7 %
13
CORTEX  AS
14
WEM INVEST AS
750 000
1,7 %
15
SANDEN EQUITY AS
16
DYVI  INVEST AS
710 000
1,6 %
17
HENRIK  MIDTTUN HAAVIE
18
DELTA  AS
641 081
1,4 %
19
GINKO  AS
20
ØYSTEIN  STRAY SPETALEN
620 874
1,4 %
560 000
1,3 %
512 324
1,2 %
508 989
1,1 %
500 000
1,1 %
468 947
1,1 %
455 500
1,0 %
444 600
1,0 %
400 000
0,9 %
350 000
0,8 %
323 650
0,7 %
Total 20 largest shareholders
Other shareholders
Total number of shares
29 845 141
67,3 %
14 499 451
32,7 %
44 344 592
100,00 %
* Board members of Vistin Pharma, or companies controlled by Board members
Vistin Pharma - Oslo Stock Exchange

Contact

Alexander Karlsen
CFO
Vistin Pharma ASA
+47 970 53 621alexander.karlsen@vistin.com
Alexander Karlsen